Pharmicell Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
33,405
20,155
25,176
27,839
25,197
28,352
Cost of Goods Sold (COGS) incl. D&A
28,166
18,616
21,736
20,467
20,086
17,345
Gross Income
5,239
1,539
3,440
7,372
5,111
11,007
SG&A Expense
13,045
13,001
10,009
9,199
9,545
10,718
EBIT
8,098
11,911
6,582
1,866
4,459
260
Unusual Expense
17,641
16,698
223
382
34,383
13,063
Non Operating Income/Expense
1,525
501
152
795
535
14
Interest Expense
1,959
912
446
186
-
57
Pretax Income
25,701
28,768
6,390
677
39,197
12,681
Consolidated Net Income
25,701
28,768
6,390
677
39,197
12,681
Net Income
25,701
28,763
6,390
677
39,197
12,681
Net Income After Extraordinaries
25,701
28,763
6,390
677
39,197
12,681
Net Income Available to Common
25,701
28,763
6,390
677
39,197
12,681
EPS (Basic)
608.00
619.00
115.00
12.00
671.00
214
Basic Shares Outstanding
42
46
55
58
58
59
EPS (Diluted)
607.88
618.62
115.17
11.74
671.27
213.60
Diluted Shares Outstanding
42
46
55
58
58
59
EBITDA
4,499
9,124
3,991
1,481
1,133
1,883
Other Operating Expense
291
449
13
38
25
29
Non-Operating Interest Income
471
252
262
197
180
165
Minority Interest Expense
-
5
-
-
-
-
About Pharmicell Co.
View Profile
